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ABSTRACT Statistical factor analysis methods have previously been used to remove noise components
from high-dimensional data prior to genetic association mapping and, in a guided fashion, to summarize
biologically relevant sources of variation. Here, we show how the derived factors summarizing pathway
expression can be used to analyze the relationships between expression, heritability, and aging. We used
skin gene expression data from 647 twins from the MuTHER Consortium and applied factor analysis to
concisely summarize patterns of gene expression to remove broad confounding influences and to produce
concise pathway-level phenotypes. We derived 930 “pathway phenotypes” that summarized patterns of
variation across 186 KEGG pathways (five phenotypes per pathway). We identified 69 significant associa-
tions of age with phenotype from 57 distinct KEGG pathways at a stringent Bonferroni threshold
(P, 5:38 · 1025). These phenotypes are more heritable (h2 ¼ 0:32) than gene expression levels. On average,
expression levels of 16% of genes within these pathways are associated with age. Several significant path-
ways relate to metabolizing sugars and fatty acids; others relate to insulin signaling. We have demonstrated
that factor analysis methods combined with biological knowledge can produce more reliable phenotypes
with less stochastic noise than the individual gene expression levels, which increases our power to discover
biologically relevant associations. These phenotypes could also be applied to discover associations with
other environmental factors.
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Aging is a multifactorial process reflecting how the physical state of an
organism accumulates changes. Among these, we observe changes in
gene expression. Microarrays and more recent RNA-seq technologies
allow the simultaneous quantification of cell population average
mRNA abundance for thousands of genes. In the case of aging, con-
sistent patterns of age-related changes in gene expression have been
observed across several tissues and species (Lu et al. 2004), such as
overexpression of inflammation and immune-response genes and
underexpression of genes involved in energy metabolism in older
samples (de Magalhaes et al. 2009). Given this commonality of func-
tion among genes that show age-related changes in expression, we
decided to investigate aging-dependent gene expression in the context
of biological knowledge of the function of genes, as provided by
pathway annotations.
Array expression experiments generate high-dimensional struc-
tured data sets in which there are correlated patterns across large
numbers of genes. Some of these are due to known technical or
biological effects such as batch effects and cell growth stage, which,
when not the focus of the analysis, can be removed by fitting them
as covariates. However, even after this, there is typically substantial
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structural correlation. In previous studies, these can be represented by
linear components of expression measurements, or factors, that can be
inferred using methods such as principal components analysis (PCA)
or factor analysis (Leek and Storey 2007; Parts et al. 2011). When the
aim is to discover local effects, such as cis genetic regulation, the
resulting factors can be treated as nuisance variables and removed
from further analysis. This has been seen to increase power in analysis
(Pickrell et al. 2010). Conversely, if the aim is to differentiate between
a case and control condition using expression, then factors viewed as
global phenotypes could be more effective classifiers than local phe-
notypes (Hastie et al. 2000).
Recently, we applied factor analysis methods in a two-stage pro-
cedure to generate phenotypes representing expressions of groups of
genes (Stegle et al. 2012). After regressing out global factors, as in
Parts et al. (2011), expression levels for groups of functionally related
genes, as defined by annotations from pathway databases, were treated
as new expression datasets and the same factor analysis methods were
used to construct pathway factors. The factors constructed on pathway
sets of genes were taken as concise summaries of common expression
variation across each pathway. We tested these factor values as phe-
notypes and refer to them as phenotype factors or, in some cases, just
phenotypes.
Here, we apply this method to gene expression data from abdominal
skin tissues from 647 samples. Unlike previous studies that have
concentrated on genetic variants that regulate multiple genes
within a pathway (Stegle et al. 2012), we focus here on discovering
associations between gene expression and age. We obtain our path-
way gene sets from the Kyoto Encyclopedia of Genes and Genomes
(KEGG) pathways (Kanehisa et al. 2004). Subsequently, by looking
for associations between these new pathway phenotypes and age,
we discover groups of functionally related genes with a common
response to aging that can be used as biomarkers describing mo-
lecular changes with age.
With data from a twin cohort containing both monozygotic and
dizygotic twins, we can estimate proportions of variance explained by
age, genetic variation, common environmental variation, and unique
environmental variation (noise). Stochasticity in gene expression,
which will form part of the unique environment component, is
believed to play a role in the aging process (Bahar et al. 2006). By
investigating sources of variation within the pathway phenotypes, we
find that they are more robust than the expression of individual genes,
with less unique environment variation. This explains some of our
success at discovering associations with age.
MATERIALS AND METHODS
Expression profiling
The data analyzed here are part of the MuTHER project (Multiple
Tissue Human Expression Resource, http://www.muther.ac.uk/; Nica
et al. 2011) and were downloaded from the ArrayExpress archive,
accession no. E-TABM-1140. In summary, the study included 856
Caucasian female individuals [336 monozygotic (MZ) and 520 dizy-
gotic (DZ) twins] recruited from the TwinsUK Adult twin registry
(Moayyeri et al. 2012). The age at sampling ranged from 39 to 85
years, with a mean age of 59 years. Punch biopsy samples (8 mm)
were taken from relatively photo-protected infra-umbilical skin. Sub-
cutaneous adipose tissue was dissected from each biopsy sample and
the remaining skin tissue was weighed and stored in liquid nitrogen.
Expression profiling of this skin tissue was performed using Illumina
Human HT-12 V3 BeadChips, with 200 ng of total RNA processed
according to the protocol supplied by Illumina. All samples were
randomized prior to array hybridization and the technical replicates
were always hybridized on different BeadChips. Raw data were im-
ported to the Illumina Beadstudio software and probes with fewer than
three beads present were excluded. Log2-transformed expression signals
were then normalized separately per tissue with quantile normalization
of the replicates of each individual followed by quantile normalization
across all individuals as previously described (Grundberg et al. 2012).
Post-QC expression profiles were subsequently obtained for 647 indi-
viduals. The Illumina probe annotations were cross-checked by map-
ping the probe sequence to the NCBI Build 36 genome with MAQ (Li
et al. 2008). Only uniquely mapping probes with no mismatches and
either an Ensembl or a RefSeq ID were kept for analysis. Probes map-
ping to genes of uncertain function (LOC symbols) and those encom-
passing a common SNP (1000G, release June 2010) were further
excluded, leaving 23,555 probes used in the analysis.
Gene expression pathway factors
In a two-step approach, factor analysis methods were first used to
discover patterns of common variation across the entire dataset. The
software package PEER (Parts et al. 2011) was applied using the de-
fault settings and using technical measurements (experimental batch,
RNA quality and concentration) as covariates to create five global
factors, which in total explained 35.7% of the variation in the dataset.
For each individual, a factor is a weighted sum of all the gene expres-
sion measurements of that individual. The weights are chosen so that
the factors iteratively explain the maximum amount of variation in the
dataset subject to certain prior assumptions; these factors produce
concise summaries of consistent patterns of expression for large num-
bers of genes.
We then used KEGG pathway annotation (186 pathways) as
prior information to group genes into pathways. This allows
inference of PEER factors for each pathway that we refer to as
phenotype factors, in contrast to the global factors previously
described. As before, these factors are weighted sums of gene
expression measurements, but in this case only of genes within the
pathway. Because global factors have been removed from the
dataset prior to calculation of phenotype factors, these factors are
unlikely to capture global effects on gene expression, but instead
capture pathway specific patterns of expression. If a large enough
module of genes within the pathway is co-expressed, then one
factor will capture the same pattern of co-expression across
individuals. Equally, groups of genes could show opposite patterns
of expression; this antagonistic gene expression can also be re-
flected as a factor value that correlates across individuals with
one set of genes and is anti-correlated with the other set of genes.
Individual genes can contribute positively or negatively to the weighted
sum (indicated by the sign of the corresponding weight), meaning that
a positive correlation between age and phenotype factor can be induced
by negative correlations with individual genes.
We grouped the expression data set into 186 pathway subsets.
For each pathway we created five pathway phenotypes using PEER
with the default settings. We consider the learned pathway factor
values across individuals as five new phenotypes that can be in-
vestigated for associations with age. An alternative strategy would
be to choose different numbers of factors based on the cumulative
amount of variance explained. For the sake of simplicity and as
a proof of principle, in this analysis we chose to use five factors
because they explained a substantial amount of the variance in
expression (17.5%) without too large of a multiple testing burden.
The sixth factor, on average, would have explained 2.2% more of
the variance.
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Pathway factor and phenotype association
Association tests were performed using the linear mixed models
defined in Box 1: between each pathway factor and chronological age
and between single genes and chronological age. These models have
been implemented by the lme4 package (Bates et al. 2014) in R
(R Core Team 2013). For each phenotype a likelihood ratio test of
the full model, which includes the age term, and the null model
(without modeling age) were used to assess evidence for an age effect.
P values produced by this analysis were assessed for significance,
allowing for multiple testing using a Bonferroni-adjusted threshold.
Permuted datasets were created that maintained the twin structure by
permuting singletons, DZ twins, and MZ twins separately and ensur-
ing that twin pairs were kept together.
Significant associations between phenotype factors and age were
further investigated to trace the particular genes within the pathway
driving the signal. We report genes with a Bonferroni significant P value
that accounts for the number of genes within the pathway that was tested.
Heritability analysis
To compute heritability, the proportion of environmental variance
explained by age, and the proportion of variance explained by unique
environment, we fitted the full model from Box 1. Then, the genetic
component to variation was estimated as twice the additional correlation
of MZ twins relative to DZ twins. The environmental component to the
phenotype was the sum of the contribution from the fixed age effect, the
random noise term, and the shared environmental component, again
estimated from the difference between MZ and DZ. Estimates of these
proportions are constrained to lie between 0 and 1 inclusive.
Single-gene based pathway enrichment analysis
We compared the significant pathways found by our factor analysis
methods to those found by looking for enrichment of single gene
associations with age. First, we tested each gene for association with
age using the methods described in Box 1 and produced a list of
Bonferroni significant genes P, 0:05 (this list contained 682 differ-
entially expressed genes). For each pathway, we applied a Fisher’s
exact test to infer whether the proportion of significantly associated
genes within the pathway was greater than would be expected by
chance. We also investigated whether using an FDR cut-off for sig-
nificant age associations would produce more significant pathways or
whether power would be diluted by including too many false positives.
When re-running the analysis using a less stringent threshold (3487
genes were associated with age with FDR, 0:05), we found fewer
significant pathways and results correlated less well with the results
of the factor based analysis [Spearman correlation of 0.36 (P =
5:1 · 1027) compared to 0.49 for Bonferroni, P = 2:1 · 10212]. A com-
plete list of all significant single-gene age associations (FDR, 0:05; 3487
genes), with estimates of effect size and direction, can be found in
Supporting Information, File S1.
RESULTS
The first stage of the analysis was to remove the effect of both known
and unknown nuisance variables from the gene expression data. Using
PEER software, we estimated five global factors that explained 35.7%
of the variation in the complete gene expression data. Because the aim
of this analysis was to find pathway specific responses to aging, we
treated these global factors as nuisance covariates and regressed these
out of the data, together with batch and RNA quality that are known
experimental confounders. Data were then divided into subsets of
genes within 186 KEGG pathways that contained more than 10 genes
with probes in our dataset. For each pathway, five factors were
estimated using PEER as described above, which explained, on
average, 17.5% of the residual variation of all genes within this
pathway after removing the global factors. For the 186 KEGG
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pathways, this produced 930 phenotypes that were tested for
association with age (see Materials and Methods for details). In total,
69 significant associations (P, 5:38 · 1025, the Bonferroni-adjusted
threshold) from 57 distinct pathways were identified. The most sig-
nificant 20 pathways are listed in Table 1, and a list of all 57 signif-
icant pathways can be found in Table S1.
We also explored an alternative method for finding pathway
related to aging, looking for enrichment in the number of significantly
associated genes falling into a particular pathway, analogous to the
method used by the DAVID methodology (Huang et al. 2009). This
discovered a total of seven significant pathways (Table S2). Thus,
applying factor analysis methods to discover significantly associated
pathways uncovered eight-times as many hits. All pathways discov-
ered by single gene enrichment methods were also discovered
using factor analysis. There is strong concordance between P values
discovered by the two methods (Spearman correlation = 0.49,
P¼ 2:1 · 10212). Figure 1 shows a Q-Q plot of P values for both
methods against the theoretical P values under the complete null
hypothesis. We see enrichment of significant P values for both meth-
ods, but this is not present when analyzing the permuted data with
factor analysis methods (green dots). This suggests that age plays
a widespread role in the expression of these pathways.
To investigate which genes drove the significant pathway associ-
ations, we examined how many genes within a significant pathway
showed significant age associations (Table 1 and Table S1). On aver-
age, 16% of genes within the pathways have P, 0:05 after adjusting
for the number of genes in the pathway, with a minimum of 1 gene
and maximum of 24. The proportion is similar between pathways of
different sizes, in contrary to the traditional pathway enrichment
analysis, where there is bias toward large pathways.
Different KEGG pathways can contain overlapping sets of genes,
because they can describe related biological function. Because of this,
our significant associations with age for different pathways could be
related as a common underlying effect on a given set of genes. To
explore whether the observed age associations are unique to their
pathway or common to multiple pathways, we calculated the Spearman
correlation between those phenotypes. There are 24 pathway pheno-
types with a correlation greater than 0.8 with at least one other
phenotype (Table S3). These phenotypes frequently relate to metabo-
lism and form a highly connected set (Figure S1). We infer from this
that there could be a common effect of age acting on these phenotype
factors. However, these form only a minority of the phenotype factors
with significant signal.
We next explored how different sources of variation in the
different phenotypes analyzed here affect our ability to discover age
associations. We calculated the heritabilities, the proportion of
environmental variance explained by age, and the proportion of
variance explained by the unique environment (Box 1) for KEGG
pathways, global factors (which we have treated as nuisance
covariates), and for individual genes (Figure 2, global factor histo-
grams are not shown because there are too few phenotypes). The
relative differences in sources of variation between global and pathway
factors and the individual genes are shown in Figure 3. We see that as
we move away from local phenotypes (individual genes) to pathway
phenotypes and then to global phenotypes, the proportion of variation
explained by unique environment decreases. This is because there is
a stochastic component to each single gene’s expression: by taking
a weighted average of a number of genes, we average away this com-
ponent. If all else were to remain constant, then this reduction in
stochastic noise would simultaneously increase heritability (as the total
variance decreases) and boost the ability to discover associations with
biological meaning, such as age. We see in the first panel of Figure 3
that the relative contribution of unique environment to pathway phe-
notypes is smaller than the contribution to genes. This also partly
explains the results shown in the second and third panels: a greater
proportion of variance is explained by age and genetic factors (heri-
tability) for pathway factors than individual gene measurements.
When considering global factors, as expected the unique environ-
ment is greatly reduced. However, there is not a strong influence of
aging and heritability in this case is still moderate. This is likely
because age and genetics do not act in a consistent way across large
sets of genes. Leek and Storey (2007) argued that global factors can
n Table 1 List of 20 pathways most significantly associated with age
KEGG_ID Pathway
P of Pathway
Factor
No. of Genes
in Pathway
Number of
Age-Associated Genes Heritability
00900 Terpenoid Backbone Biosynthesis 6.23· 10213 13 6 0.00
00980 Metabolism of Xenobiotics by Cytochrome P450 6.47· 10213 54 6 0.09
01040 Biosynthesis of Unsaturated Fatty Acids 1.11· 10212 17 6 0.25
00100 Steroid Biosynthesis 1.33· 10212 14 12 0.41
00650 Butanoate Metabolism 1.51· 10212 27 8 0.39
04146 Peroxisome 1.56· 10212 64 17 0.45
00830 Retinol Metabolism 1.93· 10212 48 6 0.45
00010 Glycolysis Gluconeogenesis 3.59· 10212 49 12 0.42
00051 Fructose and Mannose Metabolism 3.99· 10212 32 8 0.32
00290 Valine Leucine and Isoleucine Biosynthesis 1.15· 10211 11 3 0.00
00561 Glycerolipid Metabolism 2.63· 10211 38 6 0.34
00620 Pyruvate Metabolism 4.20· 10211 35 11 0.37
00770 Pantothenate and COA Biosynthesis 4.76· 10211 16 4 0.48
00280 Valine Leucine and Isoleucine Degradation 5.79· 10211 35 10 0.51
00020 Citrate Cycle TCA Cycle 1.12· 10210 23 8 0.43
04916 Melanogenesis 3.34· 10210 93 10 0.00
04910 Insulin Signaling Pathway 3.70· 10210 122 13 0.45
00565 Ether Lipid Metabolism 5.89· 10210 27 3 0.00
00350 Tyrosine Metabolism 9.44· 10210 32 4 0.34
00640 Propanoate Metabolism 1.03· 1029 26 6 0.59
List of 20 pathways most significantly associated with age, together with the total number of genes in the pathway, the number of genes within pathways significantly
associated with age (P, 0:05, corrected using Bonferroni for the total number of genes in the pathway), and the heritability of the pathway factor.
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capture experimental noise and batch effects. This is consistent with
our findings. Heritabilities and proportion of variance explained by
age for each pathway are reported in Table S4.
We also looked for novel genetic associations with these pathway
phenotypes not seen as single gene expression associations. However,
this was unsuccessful despite the increased heritability in pathway
factors. This is likely due to the genetic architecture of gene regulation.
Genes are regulated both in cis, where a nearby variant effects the
expression of a single gene, and in trans, where a long range regulatory
effect can hit multiple genes (Grundberg et al. 2012). The genetics of
pathway phenotypes is a combination of cis effects on individual genes
and trans effects, potentially affecting multiple genes in the pathway.
However, trans variants typically have much smaller effect size: the
increase in the reliability of pathway phenotypes is insufficient to
compensate for the lower power to discover trans effects. Thus, the
only associations discovered were when single genes loaded heavily
enough on a pathway to indirectly reflect a cis association that could
also be detected by a single gene test.
DISCUSSION
We have seen that both the heritability and the proportion of
environmental variance explained by age are greater for pathway
Figure 1 Q-Q plot of observed P values against theoretical P values for factor analysis (red dots) and single gene–based methods (in blue). Permutations
(in green) show the results of a combined analysis of 10 permuted datasets. Horizontal lines show Bonferroni significance thresholds accounting for different
numbers of tests (186 tests for single gene measures in blue, 930 for factor analysis in red, and 9300 for the combined 10 permutation analyses in green).
Volume 5 May 2015 | Factor Analysis Identifying Aging Phenotypes | 843
Figure 2 Histograms showing the proportion of environmental variation explained by age, heritability, and the proportion of variance explained
by the unique environment for pathway factors and the individual gene measurements.
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phenotypes than for individual genes. Consistent with this, we found
a greater proportion of associations for the pathway phenotypes
than using single gene tests using this same dataset (Glass et al.
2013; 23% compared with 7% of phenotypes are significantly as-
sociated with age when using the same 0.05 FDR threshold adopted
in that article). This can be explained by our findings regarding the
influence of unique environment on pathway phenotypes relative
to single genes.
Stochasticity in gene expression, which contributes to the unique
environment component that we measure, has been seen to increase
with age. For example, animal model studies (Bahar et al. 2006;
Herndon et al. 2002) have reported increased cell-to-cell variation
in gene expression with age- and tissue-specific decline of functions
associated with stochastic events. Others have found genes associated
with longevity to be strongly regulated in older animals with low levels
of stochasticity and higher levels of heritability (McCarroll et al. 2004;
Figure 3 The relative importance of sources of variation to global, pathway, and gene phenotypes. Measures of variation shown are the
proportion of variance explained by unique environment, proportion of variance explained by genetics (heritability), and the proportion of
environmental variation explained by age. To show more clearly the differences in relative importance of these measures to different classes of
phenotypes, all proportions are scaled such that contribution to gene phenotypes equals one. Numbers above the bars give the absolute,
unscaled proportions.
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Viñuela et al. 2012). The aim of our analysis was to find mean effects
rather than variance effects (although both effects are often seen to-
gether). By reducing the unique environment variance component
using pathway factor analysis methods, we arguably focus much more
on systematic longevity changes with age rather than the environmen-
tal stochasticity. However, it is difficult to make inference about cau-
sality with gene expression: we cannot know whether we are observing
changes in expression that are driving the aging process or markers
for it. Previous studies have suggested that the latter may be the case,
because often changes in gene expression occur in response to aging
(de Magalhaes et al. 2009).
Of the 57 significant pathways, we frequently see four types of
pathway, all of which have been previously linked with aging: insulin
signaling; sugar and fatty acid metabolism; xenobiotic metabolism;
and cancer-related pathways.
We find the insulin signaling pathway (hsa04910) to be highly
associated with age in our data (P ¼ 3:7 · 10210). Much evidence has
accumulated for the influence of the insulin signaling pathway on
longevity, originating in C. elegans, where lowered insulin/IGF-1 sig-
naling (IIS) can lead to a significant increase in life span (Friedman
and Johnson, 1988). This effect has also been seen in the fruit fly
D. melanogaster (Clancy et al. 2001) and in mice (Holzenberger et al.
2003). Outside of model organisms, it has been observed that variants
in FOXO transcription factors related to this pathway can affect lon-
gevity in humans (Willcox et al. 2008).
In addition to those related to insulin, our list of age-associated
pathways includes many that are involved in metabolism or glycolosis.
Examples of these include biosynthesis of unsaturated fatty acids
(hsa00980), butanoate metabolism (hsa00650), glycolysis gluconeo-
genesis (hsa00010), fructose and mannose metabolism (hsa00051),
and valine leucine and isoleucine biosynthesis (hsa00290). It has
previously been suggested that metabolism-related pathways play roles
in aging and aging-related diseases (Barzilai et al. 2012). In particular,
Houtkooper et al. (2011) showed that glucose and compounds in-
volved in the metabolism of glucose were biomarkers of aging in liver
and muscle tissue in mice.
Other aging-related pathways include those involved in the metab-
olism of xenobiotics that allow cells to deactivate and excrete unexpected
compounds. One example is glutathione metabolism (hsa00480,
P ¼ 1:45 · 1027); glutathione is a well-known antioxidant that protects
against cell damage by reactive oxygen species (Pompella et al. 2003).
Finally, previous studies have shown that cancer risk is positively
associated with age after childhood (Finkel et al. 2007; de Magalhães
2013). For example, cellular senescence, when a cell loses the ability to
divide, can form a break on cancer development, and clearing such
senescent cells can delay the development of age-associated disorders
(Baker et al. 2011). There are a number of pathways on our list that
have been linked to cancer, particularly skin cancer. These include
melanogenesis (hsa04916, P ¼ 3:34 · 10210), the PPAR signaling path-
way (hsa03320, P ¼ 1:83 · 1029), the hedgehog signaling pathway
(hsa04340, P ¼ 1:12 · 1027), and glioma (hsa05214, P ¼ 4:26 · 1027)
In addition to age, other phenotypes have been linked to
expression patterns of multiple genes. For example, BMI has been
linked to expression patterns in adipose tissue of multiple genes within
a group that share a common trans master regulator, and such phe-
notypes could mediate between expression and diseases such as type 2
diabetes (Small et al. 2011). Principal components and factor analysis
have also been suggested as a way to build classifiers for binary traits
(Hastie et al. 2000), perhaps to predict prognosis of disease from gene
expression data. The ability of pathway phenotypes to provide reliable
measures of expression with direct biological interpretation means
they could also be applied in these situations to understand the re-
lationship between expression and such phenotypes.
Our analysis shows that factor analysis applied to gene expression
data effectively reduces stochastic noise in summaries of gene
expression patterns, giving more power to discover associations.
These phenotypes are substantially more heritable than individual
genes. Using them we can improve our ability to identify biological
processes underpinning aging. This is consistent with the idea that
removing latent factors that exert broad effects on gene expressions
increases power in associations. We show that the same idea can be
used to create pathway factors that are robust and interpretable.
Finally, our analysis reveals pathways that have been seen to be
important in longevity from a number of previous studies as well as
novel pathways that can be further investigated.
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